|
STAT1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.33750000000677E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.122400E-02 |
| Normal-vs-Stage2 |
1.757860E-02 |
| Normal-vs-Stage3 |
2.013600E-02 |
| Normal-vs-Stage4 |
3.886800E-01 |
| Stage1-vs-Stage2 |
1.509550E-01 |
| Stage1-vs-Stage3 |
1.280590E-01 |
| Stage1-vs-Stage4 |
9.759200E-01 |
| Stage2-vs-Stage3 |
7.772200E-01 |
| Stage2-vs-Stage4 |
3.632800E-01 |
| Stage3-vs-Stage4 |
3.635000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.798100E-03 |
| Normal-vs-AfricanAmerican |
6.617600E-03 |
| Normal-vs-Asian |
2.278600E-01 |
| Caucasian-vs-AfricanAmerican |
3.532000E-01 |
| Caucasian-vs-Asian |
3.556600E-01 |
| AfricanAmerican-vs-Asian |
4.535200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.162470E-02 |
| Normal-vs-Female |
2.206600E-04 |
| Male-vs-Female |
4.239000E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.046300E-02 |
| Normal-vs-Extreme_Weight |
1.811630E-01 |
| Normal-vs-Obese |
4.664100E-03 |
| Normal-vs-Extreme_Obese |
8.562200E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.712000E-01 |
| Normal_Weight-vs-Obese |
3.364200E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.271750E-01 |
| Extreme_Weight-vs-Obese |
1.639550E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.847600E-01 |
| Obese-vs-Extreme_Obese |
1.977770E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.137800E-02 |
| Normal-vs-Age(41-60Yrs) |
7.239100E-04 |
| Normal-vs-Age(61-80Yrs) |
1.515620E-02 |
| Normal-vs-Age(81-100Yrs) |
2.627600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.487380E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.083390E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.992410E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.160600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.415180E-04 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.819600E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.363700E-03 |
| Normal-VS-Type2 PRCC |
1.225660E-02 |
| Normal-VS-KIRP CIMP |
2.141500E-02 |
| Normal-VS-Unclassified PRCC |
6.316300E-02 |
| Type1 PRCC-VS-Type2 PRCC |
7.265200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.918600E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
2.812600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.176160E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
3.628800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.937400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.310400E-02 |
| Normal-vs-N1 |
8.280300E-03 |
| Normal-vs-N2 |
2.067600E-01 |
| N0-vs-N1 |
9.980300E-02 |
| N0-vs-N2 |
7.832800E-01 |
| N1-vs-N2 |
6.278000E-01 |
|
|
